BOSTON, September 26, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the first accepted medical presentations of the Phase 3 data on the investigational once daily ...

BOSTON, June 20, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced simultaneous presentation and publication of updated data from the Phase 1/2 portion of the Phase 1/2/3 ...

CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentation at the NASDAQ OMX Investor Conference in London on ...

The presentations will be webcast live and may be accessed from the 'Events & Presentations' link under the 'Investors' tab on the home page of Vertex's website at www.vrtx.com. A replay of the ...